Savita Rangarajan

Publications

87 publications

Page 6 of 9

The clinical implications of ADAMTS13 function

Savita Rangarajan, Craig Kessler & Louis Aledort, 2013, Thrombosis Research, 132(4), 403-407

DOI: 10.1016/j.thromres.2013.07.027

Type: review

Diagnosis and management of acquired coagulation inhibitors

Peter W Collins, Elizabeth Chalmers, Daniel Hart, Ian Jennings, Ri Liesner, Savita Rangarajan, Kate Talks, Michael Williams & Charles R M Hay, 2013, British Journal of Haematology, 162(6), 758-773

DOI: 10.1111/bjh.12463

Type: article

Consensus recommendations for the use of FEIBA^® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery

S. Rangarajan, S. Austin, N. J. Goddard, C. Négrier, E. C. Rodriguez-Merchan, D. Stephensen & T. T. Yee, 2013, Haemophilia, 19(2), 294-303

DOI: 10.1111/hae.12028

Type: article

Will gene therapy trump factor treatment in hemophilia?

Savita Rangarajan & Louis Aledort, 2013, Expert Review of Hematology, 6(1), 43-48

DOI: 10.1586/ehm.12.70

Type: review

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization

Peter W Collins, Elizabeth Chalmers, Daniel P Hart, Ri Liesner, Savita Rangarajan, Kate Talks, Mike Williams & Charles R Hay, 2013, British Journal of Haematology, 160(2), 153-170

DOI: 10.1111/bjh.12091

Type: article

Hum1an-cl rhFVIII effectively and safely prevents bleeding episodes in previously treated adult patients with severe haemophilia A

S. Knaub, T. Lissitchkov, K. Hampton, S. Rangarajan, J. Bichler & J. Oldenburg, 2013, Haemophilia, 19(3), 468

Type: conference

The incidence of factor VIII inhibitors in severe haemophilia a following a major product switch in the UK: a prospective controlled study in 1214 previously treated patients

C. R. M. Hay, P. Collins, B. Palmer, R. Liesner, E. Chalmers, D. Hart, S. Rangarajan, K. Talks & M. Williams, 2013, Journal of Thrombosis and Haemostasis, 12(11), 9

Type: conference

Ageing and hemophilia: whose problem is it?.

G. Robinson, J. Schuster & S. Rangarajan, 2012, Haemophilia, 18(7), 9

Type: conference

Adenovirus-associated virus vector–mediated gene transfer in hemophilia B

Amit C. Nathwani, Edward G.D. Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny Mcintosh, David C. Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington, James O'Beirne, Keith Smith, John Pasi, Bertil Glader, Pradip Rustagi, Catherine Y.c. Ng, Mark A. Kay, Junfang Zhou, Yunyu Spence, Christopher L. Morton, James Allay, John Coleman, Susan Sleep, John M. Cunningham, Deokumar Srivastava, Etiena Basner-Tschakarjan, Federico Mingozzi, Katherine A. High, John T. Gray, Ulrike M. Reiss, Arthur W. Nienhuis & Andrew M. Davidoff, 2011, New England Journal of Medicine, 365(25), 2357-2365

DOI: 10.1056/NEJMoa1108046

Type: article

Acquired agranulocytosis and factor XI deficiency in association with thymoma

Yogesh Jethava, Jayanthi Alamelu, Savita Rangarajan, Loic Lang-Lazdunski, Jon van der Walt & Paul Fields, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29(20), e604-6

DOI: 10.1200/JCO.2010.34.3707

Type: article

Professor Savita Rangarajan

Connect with Savita

Publications